We propose a framework for transformational pharmaceutical public-private partnerships (PPPPs) to accelerate the movement of discoveries from the bench to the bedside and the rapid identification of secondary uses of existing drugs through a multi-sided platform managed by a trusted intermediary utilizing artificial intelligence (AI).
